focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK on course for COVID-19 vaccination target as shots reach 200,000 a day - Hancock

Sun, 10th Jan 2021 10:35

* UK targets 14 million shots by mid-Feb, every adult by
autumn

* New variant causing a surge in cases

* Health Secretary will not speculate on even tougher
restrictions
(Adds further details on tests, further lockdown measures)

By Paul Sandle

LONDON, Jan 10 (Reuters) - Britain is on course to have
immunised its most vulnerable people against COVID-19 by
mid-February and offering a shot to every adult by autumn, with
some 2 million people having already received a first dose, its
health secretary said on Sunday.

"Over the last week we've vaccinated more people than in the
entirety of December, so we're accelerating the roll-out," Matt
Hancock told BBC TV.

Britain is battling surging infections but is pinning its
hopes on rapid immunisation to enable life to start returning to
some degree of normality by the spring.

Hancock said around 2 million people had already received a
first shot of the Pfizer-BioNTech or the Oxford-AstraZeneca
vaccine.

"We've now vaccinated around a third of all of the over 80s,
so (we are making) very, very good progress," he said.

For the government to meet its goal of vaccinating more than
14 million people by mid-February, comprising the over-70s, the
clinically vulnerable - the elderly or with pre-existing
conditions - and health and social-care workers, it needs to
deliver 2 million shots a week.

The current rate is around 200,000 a day, Hancock said.

Seven mass vaccination centres will open this week,
supplementing almost 1,000 doctors surgeries and hospitals
offering shots. Hancock said every adult would be offered a
vaccine by the autumn.

Queen Elizabeth and her husband Philip, both in their
nineties, have received vaccinations, Buckingham Palace said on
Saturday.

SURGING CASES
A highly transmissible new variant of the virus is surging
around Britain and Prime Minister Boris Johnson has imposed a
third national lockdown in England to try to stem the pandemic
before the most vulnerable are immunised. Wales, Scotland and
Northern Ireland have imposed similar measures.

More than 80,000 people in Britain have died within 28 days
of receiving a positive COVID-19 test, the fifth highest
official death toll globally, and over 3 million people have
tested positive.

England's Chief Medical Officer Chris Whitty said on Sunday
the national health service in parts of the country was facing
"the most difficult situation anyone could remember".

Hancock did not rule out a tougher lockdown, saying he would
"not speculate" on further restrictions, although he added that
the "vast majority" of people were complying with current rules.
(
Editing by Mark Heinrich and Frances Kerry)

More News
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.